UNION therapeutics A/S: Financial statements 2018
CVR: 33963750
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
UNION therapeutics A/S (CVR 33963750) has filed annual accounts for 2018. In 2018, the company reported a net result of USD -7,798,346 compared with USD -5,396,630 the year before. Equity in the 2018 report amounted to USD -5,293,947.
- Revenue
- USD 0
- Profit/Loss
- USD -7,798,346
- Equity
- USD -5,293,947
- Total Assets
- USD 4,394,631
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 0 USD | - | -7.8M USD | -5.3M USD | - |
| 2017 | 315K USD | - | -5.4M USD | 1.9M USD | - |
| 2016 | 729K USD | -343K USD | -485K USD | -195K USD | - |
| 2015 | 691K USD | -154K USD | -224K USD | -71K USD | - |
| 2014 | - | 3.1M | 578K | 988K | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
On October 5, 2018, the company changed its name from AntibioTx A/S to UNION therapeutics A/S.
UNION therapeutics A/S has published its annual report for 2017. Revenue came to DKK 315,394, and the net result was DKK -5,396,630.
As of April 1, 2018, Morten Højland Boesen is registered as director of UNION therapeutics A/S.
About UNION therapeutics A/S
UNION therapeutics A/S is a Danish company of the type Aktieselskab based in Hellerup, founded in 2011. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named AntibioTx A/S and ANTIBIOTX ApS. The management consists of Kim Domela Kjøller, Morten Otto Alexander Sommer and Rasmus Vendler Toft-Kehler. The board consists of Stig Løkke Pedersen (chair), Andrew John Oakley, Morten Otto Alexander Sommer and Peter Kristensen. The company's owners include MANJIN ApS, VENDLER ApS and T&W HOLDING A/S. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -11,802,644 and a net result of DKK -32,142,051 compared with DKK -98,922,000 the year before. Equity in the 2025 report amounted to DKK -147,650,138.